| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | Israel | 3 | |
| #3 | United States | 3 | |
| #4 | African Regional Industrial Property Organization | 2 | |
| #5 | Argentina | 2 | |
| #6 | Australia | 2 | |
| #7 | Canada | 2 | |
| #8 | China | 2 | |
| #9 | Colombia | 2 | |
| #10 | Costa Rica | 2 | |
| #11 | Cuba | 2 | |
| #12 | EAPO (Eurasian Patent Organization) | 2 | |
| #13 | Ecuador | 2 | |
| #14 | EPO (European Patent Office) | 2 | |
| #15 | Hong Kong | 2 | |
| #16 | Republic of Korea | 2 | |
| #17 | Morocco | 2 | |
| #18 | Mexico | 2 | |
| #19 | Peru | 2 | |
| #20 | Singapore | 2 | |
| #21 | Tunisia | 2 | |
| #22 | Taiwan | 2 | |
| #23 | Uruguay | 2 | |
| #24 | Brazil | 1 | |
| #25 | Chile | 1 | |
| #26 | South Africa | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Organic fine chemistry | |
| #3 | Computer technology | |
| #4 | Chemical engineering |
| # | Technology | |
|---|---|---|
| #1 | Heterocyclic compounds | |
| #2 | Therapeutic chemical compounds | |
| #3 | Medical preparations | |
| #4 | Computational chemistry | |
| #5 | Chemical or physical processes |
| # | Name | Total Patents |
|---|---|---|
| #1 | Almstetter Michael | 48 |
| #2 | Treml Andreas | 47 |
| #3 | Thormann Michael | 46 |
| #4 | Koestler Roland | 24 |
| #5 | Yehia Nasser | 24 |
| #6 | Traube Nadine | 23 |
| #7 | Michael Almstetter | 4 |
| #8 | Michael Thormann | 4 |
| #9 | Andreas Treml | 4 |
| #10 | Nadine Traube | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021048618A1 | 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune disease | |
| WO2021048620A1 | 1,4-dihydrobenzo[d]pyrazolo[3,4-f][1,3]diazepine derivatives and related compounds as lrrk2, nuak1 and/or tyk2 kinase modulators for the treatment of e.g. autoimmune disease | |
| US2015266882A1 | Pyrazolo[4,3-D]pyrimidines as kinase inhibitors | |
| US2015259340A1 | Kinase inhibitors | |
| AU2012244549A1 | Heterocyclic compounds as kinase inhibitors | |
| MX2013012294A | Pyrazolo [4, 3-d] pyrimidines useful as kinase inhibitors. |